Your browser doesn't support javascript.
loading
Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history.
Nishiyama, Takara; Miyamatsu, Yuichiro; Park, Hyeongki; Nakamura, Naotoshi; Yokokawa Shibata, Risa; Iwami, Shingo; Nagasaki, Yoji.
Afiliación
  • Nishiyama T; interdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan.
  • Miyamatsu Y; Department of Neurosurgery, National Hospital Organization Kyushu Medical Center, Fukuoka 810-8563, Japan; Division of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-0054, Japan.
  • Park H; interdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan.
  • Nakamura N; interdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan.
  • Yokokawa Shibata R; Department of Advanced Transdisciplinary Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Iwami S; interdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan; Institute of Mathematics for Industry, Kyushu University, Fukuoka 819-0395, Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto Univer
  • Nagasaki Y; Department of Infectious Disease, Clinical Research Institute, National Hospital Organization Kyushu Medical Center,1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-8563, Japan. Electronic address: yoji.basser@gmail.com.
Vaccine ; 41(52): 7655-7662, 2023 Dec 18.
Article en En | MEDLINE | ID: mdl-38008663

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Formación de Anticuerpos Límite: Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Formación de Anticuerpos Límite: Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Japón